All sites C00-96,D32-33,D42-43,D45-47,D76 618 89.7 2.7 1.7 3.4 2.6
Mouth, pharynx C00-14 12 98.3 - - 1.7 -
  Lip C00 1 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 4 95.0 - - 5.0 -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 3 100.0 - - - -
Digestive organs C15-26 113 81.2 2.7 4.8 6.9 4.4
  Oesophagus C15 4 100.0 - - - -
  Stomach C16 12 85.0 1.7 1.7 6.7 5.0
  Small intestine C17 2 88.9 - - - 11.1
  Colon C18 39 94.9 - 1.0 2.6 1.5
  Rectum, rectosigmoid C19-20 20 94.9 - - 3.1 2.0
  Anus C21 1 100.0 - - - -
  Liver C22 6 75.0 7.1 7.1 7.1 3.6
  Gallbladder, bile ducts C23-24 7 66.7 6.1 9.1 12.1 6.1
  Pancreas C25 21 45.8 9.3 17.8 19.6 7.5
  Other digestive organs C26 2 37.5 - - - 62.5
Respiratory organs C30-39 40 68.3 9.9 5.0 9.9 6.9
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 39 67.2 10.3 5.1 10.3 7.2
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 1 75.0 - - 25.0 -
Melanoma of the skin C43 25 100.0 - - - -
Skin, non-melanoma C44 40 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 5 92.6 - - 7.4 -
Breast C50 183 98.5 1.4 - 0.1 -
Female genital organs C51-58 68 92.3 2.1 1.5 2.1 2.1
  Cervix uteri C53 7 100.0 - - - -
  Corpus uteri C54 28 100.0 - - - -
  Uterus, other C55,C58 0 - - - 50.0 50.0
  Ovary C56 23 82.8 4.3 4.3 4.3 4.3
  Other female genital C51-52,C57 9 91.1 4.4 - 2.2 2.2
Urinary organs C64-68 29 91.8 - 2.0 4.1 2.0
  Kidney C64 17 88.2 - 3.5 7.1 1.2
  Bladder and urinary tract2 C65-68 12 96.8 - - - 3.2
Eye C69 1 66.7 - - 33.3 -
Brain, central nervous system C70-72,D32-33,D42-43 21 93.2 - 1.0 1.9 3.9
Thyroid gland C73 10 96.1 3.9 - - -
Other endocrine glands C74-75 1 66.7 - - - 33.3
Illdefined or unknown C76,C80 13 52.2 9.0 7.5 17.9 13.4
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 55 82.2 6.9 0.7 4.4 5.8
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 20 98.0 1.0 - 1.0 -
  Malignant immunoproliferative diseases C88 1 80.0 - 20.0 - -
  Myeloma and other plasma cell tumors C90 8 80.5 7.3 2.4 7.3 2.4
  Leukaemia C91-95 11 62.5 19.6 - 7.1 10.7
  Myelodysplastic syndromes D46 3 35.7 7.1 - - 57.1
  Myeloproliferaitive neoplasms D45,D47 10 84.6 5.8 - 7.7 1.9
Not included above
  Carcinoma in situ of the breast D05 12 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 18 100.0 - - - -
  Borderline tumour of the ovary D39 3 93.3 - - 6.7 -
  Basal cell carcinoma of the skin 172 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.